Roger Esteban-Fabró

4PUBLICATIONS
68CO-AUTHORS
Molecular targetsHaematological tumoursCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 23, 2025
E7386 Enhances Lenvatinib's Antitumor Activity in Preclinical Models and Human Hepatocellular Carcinoma.

Agavni Mesropian, Albert Gris-Oliver, Ugne Balaseviciute

|Feb 19, 2025
Human-correlated genetic models identify precision therapy for liver cancer.

Miryam Müller, Stephanie May, Holly Hall

|Aug 23, 2022
Hepatocellular Carcinoma in Mongolia Delineates Unique Molecular Traits and a Mutational Signature Associated with Environmental Agents.

Laura Torrens, Marc Puigvehí, Miguel Torres-Martín

|Mar 18, 2022
Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma.

Roger Esteban-Fabró, Catherine E Willoughby, Marta Piqué-Gili

Pageof 1